Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Capital Employed (2016 - 2026)

Pharma-Bio Serv filings provide 14 years of Return on Capital Employed readings, the most recent being 6.22% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed rose 116.0% to 6.22% in Q1 2026 year-over-year; TTM through Jan 2026 was 6.22%, a 116.0% increase, with the full-year FY2025 number at 4.82%, up 312.0% from a year prior.
  • Return on Capital Employed hit 6.22% in Q1 2026 for Pharma-Bio Serv, down from 5.37% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 7.64% in Q3 2023 to a low of 20.97% in Q3 2022.
  • Median Return on Capital Employed over the past 5 years was 5.45% (2025), compared with a mean of 4.34%.
  • Biggest five-year swings in Return on Capital Employed: plummeted -2665bps in 2022 and later surged 2861bps in 2023.
  • Pharma-Bio Serv's Return on Capital Employed stood at 6.39% in 2022, then decreased by -3bps to 6.23% in 2023, then crashed by -243bps to 8.93% in 2024, then soared by 40bps to 5.37% in 2025, then fell by -16bps to 6.22% in 2026.
  • The last three reported values for Return on Capital Employed were 6.22% (Q1 2026), 5.37% (Q4 2025), and 5.45% (Q3 2025) per Business Quant data.